Skip to main content
Top
Published in: Acta Diabetologica 4/2016

01-08-2016 | Original Article

Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)]

Authors: Yasuaki Hayashino, Shintaro Okamura, Satoru Tsujii, Hitoshi Ishii

Published in: Acta Diabetologica | Issue 4/2016

Login to get access

Abstract

Aims

To assess the prospective association between baseline serum uric acid level and subsequent risk of development or progression in albuminuria.

Methods

Longitudinal data were obtained from 2518 patients with type 2 diabetes in the development cohort and registered in a Japanese diabetes registry. To assess the independent correlations between baseline serum uric acid quartiles and either the development or progression of diabetic nephropathy for 2 years, the Cox proportional hazards model was used and adjusted for potential confounders.

Results

The mean patient age, body mass index, and glycated hemoglobin (HbA1c) level were 66.1 years, 24.6 kg/m2, and 7.5 % (57.6 mmol/mol), respectively. The baseline serum uric acid levels, with mean values of 3.6, 4.9, 5.8, and 7.3 mg/dL from the first to fourth quartiles, were significantly associated with the urinary albumin/creatinine ratio at baseline (p < 0.001). Baseline uric acid levels were not significantly associated with the development of nephropathy, but they were with the progression of nephropathy. The multivariable-adjusted hazards ratios for the progression from microalbuminuria to macroalbuminuria were 2.17 [95 % confidence interval (CI) 1.15–4.08; p = 0.016], 3.04 (95 % CI 1.67–5.53; p < 0.001), and 3.56 (95 % CI 1.83–6.93; p < 0.0011) for the first, third, and fourth quartiles of serum uric acid levels, respectively, as compared to that for the second quartile. We did not observe significant association between uric acid levels and change in estimated glomerular filtration rate.

Conclusions

Low and high serum uric levels, independent of possible confounders, were associated with a subsequent risk of progression, not development, in albuminuria in type 2 diabetes patients. Therefore, serum uric acid levels may be useful for predicting the future risk of progression of microalbuminuria.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127–1133CrossRefPubMed Ritz E, Orth SR (1999) Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341:1127–1133CrossRefPubMed
2.
go back to reference Caramori ML, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49:1399–1408CrossRefPubMed Caramori ML, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49:1399–1408CrossRefPubMed
3.
go back to reference Gerstein HC et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426CrossRefPubMed Gerstein HC et al (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286:421–426CrossRefPubMed
4.
5.
go back to reference Rossing P (2006) Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49:11–19CrossRefPubMed Rossing P (2006) Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. Diabetologia 49:11–19CrossRefPubMed
6.
go back to reference Rossing P (2006) Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6:479–483CrossRefPubMed Rossing P (2006) Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6:479–483CrossRefPubMed
7.
go back to reference Mazzali M et al (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991–F997CrossRefPubMed Mazzali M et al (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:F991–F997CrossRefPubMed
8.
go back to reference Domrongkitchaiporn S et al (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16:791–799CrossRefPubMed Domrongkitchaiporn S et al (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16:791–799CrossRefPubMed
9.
go back to reference Iseki K et al (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642–650CrossRefPubMed Iseki K et al (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44:642–650CrossRefPubMed
10.
go back to reference Ishani A et al (2006) Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17:1444–1452CrossRefPubMed Ishani A et al (2006) Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17:1444–1452CrossRefPubMed
12.
go back to reference Ficociello LH et al (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33:1337–1343CrossRefPubMedPubMedCentral Ficociello LH et al (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33:1337–1343CrossRefPubMedPubMedCentral
13.
go back to reference Fukui M et al (2008) Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57:625–629CrossRefPubMed Fukui M et al (2008) Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57:625–629CrossRefPubMed
14.
go back to reference Tseng CH (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68:796–801CrossRefPubMed Tseng CH (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68:796–801CrossRefPubMed
15.
go back to reference Hayashino Y et al (2012) The association between problem areas in diabetes scale scores and glycemic control is modified by types of diabetes therapy: diabetes distress and care registry in Tenri (DDCRT 2). Diabetes Res Clin Pract 97:405–410CrossRefPubMed Hayashino Y et al (2012) The association between problem areas in diabetes scale scores and glycemic control is modified by types of diabetes therapy: diabetes distress and care registry in Tenri (DDCRT 2). Diabetes Res Clin Pract 97:405–410CrossRefPubMed
16.
go back to reference Tsujii S, Hayashino Y, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group (2012) Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 1). Diabet Med 29:1451–1455CrossRefPubMed Tsujii S, Hayashino Y, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group (2012) Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 1). Diabet Med 29:1451–1455CrossRefPubMed
17.
go back to reference Mashitani T et al (2013) Patient-reported adherence to insulin regimen is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3). Diabetes Res Clin Pract 100:189–194CrossRefPubMed Mashitani T et al (2013) Patient-reported adherence to insulin regimen is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3). Diabetes Res Clin Pract 100:189–194CrossRefPubMed
18.
go back to reference Hayashino Y, Mashitani T, Tsujii S, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group (2014) Elevated levels of hs-CRP are associated with high prevalence of depression in Japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6). Diabetes Care 37:2459–2465CrossRefPubMed Hayashino Y, Mashitani T, Tsujii S, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group (2014) Elevated levels of hs-CRP are associated with high prevalence of depression in Japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6). Diabetes Care 37:2459–2465CrossRefPubMed
19.
go back to reference Hayashino Y, Mashitani T, Tsujii S, Ishii H (2014) Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese Type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]). Diabetes Care 37:2947–2952CrossRefPubMed Hayashino Y, Mashitani T, Tsujii S, Ishii H (2014) Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese Type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]). Diabetes Care 37:2947–2952CrossRefPubMed
20.
go back to reference Mashitani T, Hayashino Y, Okamura S, Tsujii S, Ishii H (2014) Correlations between serum bilirubin levels and diabetic nephropathy progression among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]). Diabetes Care 37:252–258CrossRefPubMed Mashitani T, Hayashino Y, Okamura S, Tsujii S, Ishii H (2014) Correlations between serum bilirubin levels and diabetic nephropathy progression among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 5]). Diabetes Care 37:252–258CrossRefPubMed
21.
go back to reference Hayashino Y, Tsujii S, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group  (2013) High frequency of non-nocturnal hypoglycemia was associated with poor sleep quality measure by Pittsburg Sleep Quality Index in patients with diabetes receiving insulin therapy: Diabetes Distress and Care Registry at Tenri (DDCRT 4). Exp Clin Endocrinol Diabetes 121:628–634CrossRefPubMed Hayashino Y, Tsujii S, Ishii H, Diabetes Distress and Care Registry at Tenri Study Group  (2013) High frequency of non-nocturnal hypoglycemia was associated with poor sleep quality measure by Pittsburg Sleep Quality Index in patients with diabetes receiving insulin therapy: Diabetes Distress and Care Registry at Tenri (DDCRT 4). Exp Clin Endocrinol Diabetes 121:628–634CrossRefPubMed
22.
go back to reference The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1:212–228 (2010) The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1:212–228 (2010)
23.
go back to reference Matsuo S et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
24.
go back to reference Molitch ME et al (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1):S79–S83PubMed Molitch ME et al (2004) Nephropathy in diabetes. Diabetes Care 27(Suppl 1):S79–S83PubMed
25.
go back to reference Wada T et al (2014) Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18:613–620CrossRefPubMed Wada T et al (2014) Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 18:613–620CrossRefPubMed
26.
go back to reference Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14:1707–1723CrossRefPubMed Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14:1707–1723CrossRefPubMed
27.
go back to reference Brown ER, Ibrahim JG, DeGruttola V (2005) A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 61:64–73CrossRefPubMed Brown ER, Ibrahim JG, DeGruttola V (2005) A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 61:64–73CrossRefPubMed
28.
go back to reference Heinzl H, Kaider A (1997) Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 54:201–208CrossRefPubMed Heinzl H, Kaider A (1997) Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 54:201–208CrossRefPubMed
29.
go back to reference Johnson RJ et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190CrossRefPubMed Johnson RJ et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190CrossRefPubMed
30.
go back to reference Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB (1999) Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33:225–234CrossRefPubMed Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB (1999) Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33:225–234CrossRefPubMed
31.
go back to reference Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318–321CrossRefPubMed Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318–321CrossRefPubMed
32.
go back to reference Mene P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26:2085–2092CrossRefPubMed Mene P, Punzo G (2008) Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 26:2085–2092CrossRefPubMed
33.
go back to reference Sanchez-Lozada LG et al (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67:237–247CrossRefPubMed Sanchez-Lozada LG et al (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67:237–247CrossRefPubMed
34.
36.
go back to reference Rosolowsky ET et al (2008) High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 3:706–713CrossRefPubMedPubMedCentral Rosolowsky ET et al (2008) High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 3:706–713CrossRefPubMedPubMedCentral
37.
go back to reference Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58:1668–1671CrossRefPubMedPubMedCentral Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58:1668–1671CrossRefPubMedPubMedCentral
38.
go back to reference Jalal DI et al (2010) Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 25:1865–1869CrossRefPubMedPubMedCentral Jalal DI et al (2010) Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 25:1865–1869CrossRefPubMedPubMedCentral
39.
go back to reference Tanaka K et al (2015) Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes. J Diabetes Investig 6:98–104CrossRefPubMed Tanaka K et al (2015) Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes. J Diabetes Investig 6:98–104CrossRefPubMed
40.
go back to reference Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858–6862CrossRefPubMedPubMedCentral Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858–6862CrossRefPubMedPubMedCentral
41.
go back to reference Pan HZ et al (2010) The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 47(Suppl 1):71–76CrossRefPubMed Pan HZ et al (2010) The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 47(Suppl 1):71–76CrossRefPubMed
42.
go back to reference Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257–267CrossRefPubMed Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257–267CrossRefPubMed
43.
go back to reference Lee SM et al (2009) Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 29:79–85CrossRefPubMed Lee SM et al (2009) Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol 29:79–85CrossRefPubMed
44.
go back to reference Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51–59CrossRefPubMed Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47:51–59CrossRefPubMed
45.
go back to reference Dosemeci M, Wacholder S, Lubin JH (1990) Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 132:746–748PubMed Dosemeci M, Wacholder S, Lubin JH (1990) Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 132:746–748PubMed
Metadata
Title
Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)]
Authors
Yasuaki Hayashino
Shintaro Okamura
Satoru Tsujii
Hitoshi Ishii
Publication date
01-08-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0825-x

Other articles of this Issue 4/2016

Acta Diabetologica 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.